⌘K

Login Start Free

Home/Filings/4/0001104659-20-138200

4//SEC Filing

Walsh Angela 4

Accession 0001104659-20-138200

CIK 0001818844other

View on SEC.gov Company Profile

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 8:11 PM ET

Size

5.1 KB

Accession

0001104659-20-138200

Insider Transaction Report

Form 4

Period: 2020-12-21

Virios Therapeutics, Inc.VIRI

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2020-12-21+41,412→ 41,412 total
Exercise: $10.00From: 2020-12-21Exp: 2030-12-21→ Common Stock (41,412 underlying)

Documents

1 file

4
tm2039099-2_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Virios Therapeutics, Inc.

CIK 0001818844

Entity typeother

Related Parties

1

filerCIK 0001825987

Filing Metadata

Form type: 4
Filed: Dec 20, 7:00 PM ET
Accepted: Dec 21, 8:11 PM ET
Size: 5.1 KB

View on SEC.gov